Liminatus Pharma LLC (LIMN) Net earnings per share growth forecast for next year

Symbol and logo of brand Liminatus Pharma Corp (LIMN)

Liminatus Pharma (LIMN) maintains authority in the field of oncoimmunology through advanced scientific research. The prospective EPS growth vector for the coming year in the GURU.Markets system illustrates the trend of expectations, where the 0.00 mark indicates the current state. The brand's financial stability relies entirely on venture capital infusions and R&D, as there are currently no sales. The company is currently building reputational capital by creating innovative CAR-T platforms to combat solid tumors.

LIMN - Liminatus Pharma Corp Earnings growth forecast for next year over the range 05/02/2025 - 11/17/2026

Metric breakdowns and analytics for Liminatus Pharma Corp (LIMN)

- price and consensus price forecast:
Analysis of all company metrics:Liminatus Pharma Corp
Core merchandise of Liminatus Pharma Inc.

The stability of Liminatus Pharma (LIMN) depends on successes in cell therapy and the effectiveness of clinical trials. This metric measures the sensitivity of consensus forecasts to macroeconomic shifts, reflecting the reaction of institutional capital to changes in fundamental expectations. Investors should evaluate the asset through the dynamics of expected net earnings per share growth for next year, interpreting it as an indicator of market confidence in the commercialization of drugs.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotech - Expected earnings per share growth for next year|LAVA Therapeutics N.V. (LVTX) - Expected net earnings per share growth next year|NXTC - Net earnings per share growth forecast for next year|LPTX: Net earnings per share growth forecast for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year